) --

Onyx Pharmaceuticals



) is trading at unusually high volume Monday with 4.7 million shares changing hands. It is currently at 4.2 times its average daily volume and trading up $5.97 (+15.8%) at $43.65 as of 2:36 p.m. ET.

Onyx has a market cap of $2.45 billion and is part of the

health care

sector and


industry. Shares are up 2.2% year to date as of the close of trading on Friday.

Onyx Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies that target the molecular mechanisms causing cancer the United States, Canada, and Europe.

TheStreet Ratings rates Onyx as a


. The company's strengths can be seen in multiple areas, such as its solid stock price performance and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. You can view the full

Onyx Ratings Report


See all heavy volume stocks in our

stocks moving on unusual volume list

or get investment ideas from our

investment research center


Interested in other stocks that are rising on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting


to 95370 or select from

multiple alert options